Menorrhagia and the Menopausal Transition

Amparo Carrasco-Catena, Orly Morgan, Rocío Belda-Montesinos, Antonio Rico Cano
In: ISGE Series · 2024 · pp. 167–180 · doi:10.1007/978-3-031-55300-4_13 · W4399402965
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-13 ⓘ

Menorrhagia during the menopausal transition is often associated with acceptable estrogen levels and requires histological investigation, with hormonal management or surgery as treatment options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text ⓘ

This chapter discusses menorrhagia and abnormal bleeding patterns during the menopausal transition, drawing on the SWAN study and related staging frameworks to describe how cycle irregularities relate to estrogen status. It reports that SWAN observed bleeding episodes occurring with acceptable estrogen levels, while amenorrhea was associated with low or undetectable estrogens, and emphasizes that bleeding disturbances require appropriate diagnostic evaluation, with mandatory histological investigation. The chapter notes that treatment should target any organic pathologies, whereas bleeding with an anovulatory background may be managed with hormonal treatment and that surgery can be an option for some women, with an explicit caveat that bleeding prevalence and types vary across studies. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 13,834 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

The menopausal transition in defined by the presence of clinically evident irregularities in the cycle. Prevalence and type of bleeding disturbances varies among studies. The Study of Women’s Health Across the Nation (SWAN) reveals that bleeding is usually associated with acceptable estrogen levels while amenorrhea is associated with low or undetectable estrogens. Bleeding episodes require an appropriate diagnosis, where histological investigation is mandatory. Treatment should address the organic pathologies, when present. Bleeding with anovulatory background may be managed with hormonal treatment. Surgery represents a desired option for some women. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

World Health Organization. WHO Scientific Group on Research on the Menopause in the 1990s. WHO Technical Report Series. Genevad: WHO; 1996. http://apps.who.int/iris/bitstream/10665/41841/1/WHO_TRS_866.pdf. Accessed 27Aug 2022 Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001;76:874–8. Harlow S, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;97:843–51. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, Salamone L, Stellato R. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463–73. https://doi.org/10.1093/aje/152.5.463. PMID: 10981461 Mansfield PK, Carey M, Anderson A, Barsom SH, Koch PB. Staging the menopausal transition: data from the TREMIN Research Program on Women’s Health. Womens Health Issues. 2004;14(6):220–6. https://doi.org/10.1016/j.whi.2004.08.002. PMID: 15589772 https://researchdata.edu.au/melbourne-womens-midlife-health-project/97876. Accessed 27 Aug 2022. Woods NF, Mitchell ES. The Seattle Midlife Women’s Health Study: a longitudinal prospective study of women during the menopausal transition and early postmenopause. Womens Midlife Health. 2016;9(2):6. https://doi.org/10.1186/s40695-016-0019-x. PMID: 30766702; PMCID: PMC6299967 Carlson LJ, Shaw ND. Development of ovulatory menstrual cycles in adolescent girls. J Pediatr Adolesc Gynecol. 2019;32(3):249–53. https://doi.org/10.1016/j.jpag.2019.02.119. Epub 2019 Feb 14. PMID: 30772499; PMCID: PMC6570576 Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105(11):3361–73. https://doi.org/10.1210/clinem/dgaa513. PMID: 32770239; PMCID: PMC7486884 Visser JA. Shaping up the function of anti-Müllerian hormone in ovaries of mono-ovulatory species. Hum Reprod. 2016;31(7):1403–5. https://doi.org/10.1093/humrep/dew101. Epub 2016 May 9. PMID: 27165619 Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999;84(1):105–11. https://doi.org/10.1210/jcem.84.1.5381. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996;81(3):1038–45. https://doi.org/10.1210/jcem.81.3.8772573. PMID: 8772573 Shaw ND, Srouji SS, Welt CK, Cox KH, Fox JH, Adams JA, Sluss PM, Hall JE. Compensatory increase in ovarian aromatase in older regularly cycling women. J Clin Endocrinol Metab. 2015;100(9):3539–47. https://doi.org/10.1210/JC.2015-2191. Epub 2015 Jun 30. PMID: 26126208; PMCID: PMC4570155 Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric. 1998;1(1):18–25. https://doi.org/10.3109/13697139809080677. Santoro N, Crawford SL, El Khoudary SR, Allshouse AA, Burnett-Bowie SA, Finkelstein J, Derby C, Matthews K, Kravitz HM, Harlow SD, Greendale GA, Gold EB, Kazlauskaite R, McConnell D, Neal-Perry G, Pavlovic J, Randolph J, Weiss G, Chen HY, Lasley B. Menstrual cycle hormone changes in women traversing menopause: study of women’s health across the nation. J Clin Endocrinol Metab. 2017;102(7):2218–29. https://doi.org/10.1210/jc.2016-4017. PMID: 28368525; PMCID: PMC5505186 Santoro N, Crawford SL, Lasley WL, Luborsky JL, Matthews KA, McConnell D, Randolph JF Jr, Gold EB, Greendale GA, Korenman SG, Powell L, Sowers MF, Weiss G. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008;93(5):1711–21. https://doi.org/10.1210/jc.2007-2165. Epub 2008 Feb 19. PMID: 18285413; PMCID: PMC2386686 Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: signs, symptoms, and management options. J Clin Endocrinol Metab. 2021;106(1):1–15. https://doi.org/10.1210/clinem/dgaa764. PMID: 33095879 Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause. 2009;16(1):50–9. https://doi.org/10.1097/GME.0b013e31817ee0c2. PMID: 18978637 Wise PM. Neuroendocrine ageing: its impact on the reproductive system of the female rat. J Reprod Fertil Suppl. 1993;46:35–46. PMID: 8100275 Cano A, Gimeno F, Fuente T, Parrilla JJ, Abad L. The positive feedback of estradiol on gonadotropin secretion in women with perimenopausal dysfunctional uterine bleeding. Eur J Obstet Gynecol Reprod Biol. 1986;22(5–6):353–8. https://doi.org/10.1016/0028-2243(86)90125-5. PMID: 3095159 Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA. 2004;292(24):2991–6. https://doi.org/10.1001/jama.292.24.2991. Erratum in: JAMA. 2005 Jan 12; 293(2): 163. Erratum in: JAMA 2007 Jul 18; 298(3): 288. PMID: 15613667 Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13. https://doi.org/10.1016/j.ijgo.2010.11.011. Epub 2011 Feb 22. PMID: 21345435 Goldstein SR, Lumsden MA. Abnormal uterine bleeding in perimenopause. Climacteric. 2017;20(5):414–20. https://doi.org/10.1080/13697137.2017.1358921. Epub 2017 Aug 7. PMID: 28780893 Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345–51. https://doi.org/10.1016/j.fertnstert.2005.05.035. PMID: 16275228 Awiwi MO, Badawy M, Shaaban AM, Menias CO, Horowitz JM, Soliman M, Jensen CT, Gaballah AH, Ibarra-Rovira JJ, Feldman MK, Wang MX, Liu PS, Elsayes KM. Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification. Abdom Radiol (NY). 2022;47(7):2468–85. https://doi.org/10.1007/s00261-022-03545-x. Epub 2022 May 13. PMID: 35554629 Wong S, Ray CE Jr. Adenomyosis—an overview. Semin Intervent Radiol. 2022;39(1):119–22. https://doi.org/10.1055/s-0042-1742345. PMID: 35210742; PMCID: PMC8856779 Vitale SG, Haimovich S, Laganà AS, Alonso L, Di Spiezio SA, Carugno J, From the Global Community of Hysteroscopy Guidelines Committee. Endometrial polyps. An evidence-based diagnosis and management guide. Eur J Obstet Gynecol Reprod Biol. 2021;260:70–7. https://doi.org/10.1016/j.ejogrb.2021.03.017. Epub 2021 Mar 13. PMID: 33756339 Kumar S, Nepal P, Narayanasamy S, Khandelwal A, Sapire J, Ojili V. Current update on status of saline infusion sonohysterosalpingography. Abdom Radiol (NY). 2022;47(4):1435–47. https://doi.org/10.1007/s00261-022-03427-2. Epub 2022 Feb 2. PMID: 35112137 Ferry J, Farnsworth A, Webster M, Wren B. The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma. Aust N Z J Obstet Gynaecol. 1993;33(1):76–8. https://doi.org/10.1111/j.1479-828x.1993.tb02060.x. PMID: 8498946 Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120(1):197–206. https://doi.org/10.1097/AOG.0b013e318262e320. PMID: 22914421 Dreisler E, Poulsen LG, Antonsen SL, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Pérez-López FR, Simoncini T, Tremollieres F, Rees M, Ulrich LG, European Menopause and Andropause Society. EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women. Maturitas. 2013;75(2):181–90. https://doi.org/10.1016/j.maturitas.2013.03.011. Epub 2013 Apr 22. PMID: 23619009 Damle RP, Dravid NV, Suryawanshi KH, Gadre AS, Bagale PS, Ahire N. Clinicopathological spectrum of endometrial changes in peri-menopausal and post-menopausal abnormal uterine bleeding: a 2 years study. J Clin Diagn Res. 2013;7(12):2774–6. https://doi.org/10.7860/JCDR/2013/6291.3755. Epub 2013 Dec 15. PMID: 24551634; PMCID: PMC3919318 Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013;34(2):171–208. https://doi.org/10.1210/er.2012-1008. Epub 2012 Dec 13. PMID: 23238854; PMCID: PMC3610676 Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ. 2020;371:m3873. https://doi.org/10.1136/bmj.m3873. PMID: 33115755; PMCID: PMC7592147 Affinito P, Di Carlo C, Di Mauro P, Napolitano V, Nappi C. Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone. Maturitas. 1994;20(2–3):191–8. https://doi.org/10.1016/0378-5122(94)90016-7. PMID: 7715472 Karakus S, Kiran G, Ciralik H. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial. Aust N Z J Obstet Gynaecol. 2009;49(6):685–8. https://doi.org/10.1111/j.1479-828X.2009.01093.x. PMID: 20070724 Fernández-Murga L, Hermenegildo C, Tarín JJ, García-Pérez MÁ, Cano A. Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol. Climacteric. 2012;15(5):455–9. https://doi.org/10.3109/13697137.2011.644360. Epub 2012 Feb 9. PMID: 22321028 Lobo RA, Archer DF, Kagan R, Kaunitz AM, Constantine GD, Pickar JH, Graham S, Bernick B, Mirkin S. A 17β-estradiol-progesterone Oral capsule for vasomotor symptoms in postmenopausal women: a randomized controlled trial. Obstet Gynecol. 2018;132(1):161–70. https://doi.org/10.1097/AOG.0000000000002645. Erratum in: Obstet Gynecol 2018 Sep; 132(3): 786. PMID: 29889748 Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002;9(1):6–15. https://doi.org/10.1097/00042192-200201000-00003. PMID: 11791081 Rezk M, Masood A, Dawood R. Perimenopausal bleeding: patterns, pathology, response to progestins and clinical outcome. J Obstet Gynaecol. 2015;35(5):517–21. https://doi.org/10.3109/01443615.2014.977781. PMID: 25383726 Wildemeersch D. Why perimenopausal women should consider to use a levonorgestrel intrauterine system. Gynecol Endocrinol. 2016;32(8):659–61. https://doi.org/10.3109/09513590.2016.1153056. Epub 2016 Mar 1. PMID: 26930021 Meaidi A, Kuhr Skals R, Alexander Gerds T, Lidegaard O, Torp-Pedersen C. Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study. Contraception. 2020;101(5):321–6. https://doi.org/10.1016/j.contraception.2019.12.013. Epub 2020 Jan 11. PMID: 31935386 Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J, ECLIPSE Trial Collaborative Group. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368(2):128–37. https://doi.org/10.1056/NEJMoa1204724. PMID: 23301731 Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377(23):2228–39. https://doi.org/10.1056/NEJMoa1700732. PMID: 29211679 Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;11:CD000329. https://doi.org/10.1002/14651858.CD000329.pub2. Update in: Cochrane Database Syst Rev. 2019 Aug 29; 8: CD000329. PMID: 24288154 Munro MG. Endometrial ablation. Best Pract Res Clin Obstet Gynaecol. 2018;46:120–39. https://doi.org/10.1016/j.bpobgyn.2017.10.003. Epub 2017 Oct 20. PMID: 29128205 Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Carrasco-Catena, A., Morgan, O., Belda-Montesinos, R., Cano, A. (2024). Menorrhagia and the Menopausal Transition. In: Genazzani, A.R., Goldstein, S.R., Simoncini, T. (eds) Menstrual Bleeding and Pain Disorders from Adolescence to Menopause. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-031-55300-4_13 Download citation DOI: https://doi.org/10.1007/978-3-031-55300-4_13 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-55299-1 Online ISBN: 978-3-031-55300-4 eBook Packages: MedicineMedicine (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK